(Q34631699)

English

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

1 reference

Europe PubMed Central

Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

0 references

systematic review

1 reference

based on heuristic

inferred from title

Alex J. Mitchell

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

V Delaffon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

D Vancampfort

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

C U Correll

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

M De Hert

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

0 references

publication date

10 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Psychological Medicine

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

42

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

125-147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Receipt of diabetes services by insured adults with and without claims for mental disorders

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Atypical antipsychotics and glucose dysregulation: a systematic review

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

From silos to bridges: meeting the general health care needs of adults with severe mental illnesses.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

The prevalence of undiagnosed metabolic abnormalities in people with serious mental illness

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Promoting physical health in youth mental health services: ensuring routine monitoring of weight and metabolic indices in a first episode psychosis clinic.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Disparities in diabetes care: impact of mental illness.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Implementing clinical guidelines in psychiatry: a qualitative study of perceived facilitators and barriers

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Brazilian Consensus on second-generation antipsychotics and metabolic disorders

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

A comparison of type 2 diabetes outcomes among persons with and without severe mental illnesses

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Mental disorders and quality of diabetes care in the veterans health administration

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Belgian consensus on metabolic problems associated with atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

A Systematic Review of Mortality in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiolog

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Atypical antipsychotics in psychiatric practice: practical implications for clinical monitoring

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

From PORT to policy to patient outcomes: crossing the quality chasm

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Obesity, dyslipidaemias and smoking in an inpatient population treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Insulin sensitivity, adjusted beta-cell function and adiponectinaemia among lean drug-naive schizophrenic patients treated with atypical antipsychotic drugs: a nine-month prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Implementing a physical health strategy in a mental health service

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

An evaluation of monitoring practices in patients on second generation antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Prediabetes assessment and follow-up in older veterans with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Gaps between knowing and doing: understanding and assessing the barriers to optimal health care

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Physician patterns of metabolic screening for patients taking atypical antipsychotics: a retrospective database study

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Why don't physicians follow clinical practice guidelines? A framework for improvement

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Influence of antipsychotics on mortality in schizophrenia: systematic review.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Dysglycemia in a community sample of people treated for schizophrenia: the Diabetes in Schizophrenia in Central-South Ontario (DiSCO) study.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Clinicians' recognition of the metabolic adverse effects of antipsychotic medications.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

The metabolic syndrome and schizophrenia: the latest evidence and nursing guidelines for management.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Undiagnosed impaired fasting glucose and diabetes mellitus amongst inpatients receiving antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Prevalence and awareness of cardiovascular risk factors in patients with schizophrenia: a cross-sectional study in a low cardiovascular disease risk geographical area.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Medical complications of anorexia nervosa and bulimia nervosa

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Awareness of metabolic concerns in patients with bipolar disorder: a survey of European psychiatrists

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Do antipsychotics cost lives or save lives? Risks versus benefits from large epidemiological studies

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Treatment settings and metabolic monitoring for people experiencing first-episode psychosis.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Development of a health screening clinic.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

The effects of antipsychotic therapy on serum lipids: a comprehensive review.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Guidelines for prevention and treatment of adverse effects of antipsychotic drugs on glucose-insulin homeostasis and lipid metabolism

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Who should swing the stethoscope? An audit of baseline physical examination and blood monitoring on new patients accepted by an early intervention in psychosis team

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

"Medically cleared": how well are patients with psychiatric presentations examined by emergency physicians?

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Predictors of metabolic monitoring among schizophrenia patients with a new episode of second-generation antipsychotic use in the Veterans Health Administration

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Drawing up guidelines for the attendance of physical health of patients with severe mental illness

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Retrospective analysis of diabetes care in California Medicaid patients with mental illness.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Routine laboratory screening among newly admitted psychiatric patients: is it worthwhile?

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

A comparison of schizophrenia outpatients treated with antipsychotics with and without metabolic syndrome: findings from the CLAMORS study

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Physical health monitoring of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Physical illness and schizophrenia: a review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

21 January 2018

Successes and failures in the implementation of evidence-based guidelines for clinical practice

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Gender differences in metabolic monitoring of second-generation antipsychotic prescription

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of diabetes care among adults with serious mental illness.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring and management of metabolic risk factors in outpatients taking antipsychotic drugs: a controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Off-label use of antidepressant, anticonvulsant, and antipsychotic medications among Georgia medicaid enrollees in 2001

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic risk factors among medicaid outpatients with schizophrenia receiving second-generation antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetes treatment among VA patients with comorbid serious mental illness.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of cardiac risk factors among patients with schizophrenia and diabetes.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of baseline serum glucose and lipid testing in users of second-generation antipsychotic drugs: a retrospective, population-based study of Medicaid claims data.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Current prescribing patterns in outpatient child and adolescent psychiatric practice in central New York

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipid monitoring in patients with schizophrenia prescribed second-generation antipsychotics.

1 reference

https://api.crossref.org/works/10.1017%2FS003329171100105X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1017/S003329171100105X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21846426%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34631699&oldid=1630274573"